This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of the Air Force Materiel Command to Meridian Bioscience Inc., a foreign-owned for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments. The $154,150.00 contract is for the delivery of in vitro diagnostic substances, reagents, test kits, and sets, with a period of performance ending on September 30, 2018. There was no set-aside designation used for this award. Meridian Bioscience...
This is a firm-fixed-price Blanket Purchase Agreement (BPA) call order awarded by the U.S. Department of the Air Force Materiel Command to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic substances, reagents, test kits, and sets. The $167,063 contract provides clinical diagnostic products and supplies to support federal health and screening programs. Meridian Bioscience has previously delivered COVID-19 tests, lead testing systems, hepatitis assays,...
This is a BPA Call contract awarded by the Indian Health Service, a civilian agency, to Biomerieux Inc. for $172,680.00. The contract is for the provision of test kits and quality control products, with a period of performance running until March 26, 2026. The contract does not have a set-aside designation. Biomerieux Inc., a global leader in in vitro diagnostics, will be the prime contractor providing its specialized diagnostic platforms, reagents, and test kits to support infectious disease...
This contract award is for a Blanket Purchase Agreement (BPA) call slip from the Indian Health Service (IHS) to Biomerieux Inc., a global leader in in vitro diagnostics. The $236,953.95 firm-fixed-price contract covers the procurement of Biomerieux diagnostic supplies, including reagents and test kits, to support the IHS's clinical laboratory operations. Biomerieux Inc. is the prime contractor and holds several Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $194 million...
The U.S. Department of Health and Human Services, Indian Health Service awarded a Blanket Purchase Agreement (BPA) call order to Biomerieux Inc. for BioFire panel reagents. The contract has a ceiling value of $1,216,476.00 and a period of performance through May 5, 2026. This BPA call order is under the larger Federal Supply Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits, which allows various federal agencies to procure Biomerieux's proprietary diagnostic products and...
This federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, involves the supply of BIOMERIEUX PREVICOLOR SUPPLIES against a Blanket Purchase Agreement (BPA) with the Indian Health Service, a civilian agency within the Department of Health and Human Services. The award, valued at $13,419.95, is a firm-fixed-price contract call under a Multiple Award Schedule (MAS) contract. The contract has no set-aside designation and provides for the delivery of specialized...
The federal contract award is for a Blanket Purchase Agreement (BPA) Call from the Indian Health Service, a civilian agency, to Biomerieux Inc. for the VIDAS 3 BPA. The contract has a ceiling value of $162,000.00 and a completion date of August 19, 2029. Biomerieux Inc., a for-profit organization and manufacturer of goods, is the prime contractor. The contract does not have a set-aside designation. This award is part of a larger Indefinite Delivery Vehicle (IDV) and Federal Supply Schedule...
This federal contract award to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments, is for the provision of laboratory reagents for the Centers for Disease Control and Prevention (CDC) Pittsburgh facility. The contract, valued at $49,466.00, is a firm fixed-price purchase order with an ultimate completion date of November 1, 2024. The contract does not have a set-aside designation. Meridian Bioscience is a key supplier of...
This federal contract award is a Blanket Purchase Agreement (BPA) Call valued at $69,870.49 to Biomerieux Inc., a global leader in in vitro diagnostics. The contract was awarded by the Indian Health Service, a civilian agency, for the provision of BioFire panel reagents. The contract has no set-aside designation and is being fulfilled under the In Vitro Diagnostics, Reagents, Test (FSS-65-VII) Federal Supply Schedule contract. Biomerieux Inc., through its Vitek Systems, Inc. division, has been...
This firm-fixed-price blanket purchase agreement (BPA) call was awarded by the Department of Health and Human Services' Indian Health Service to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $13,419.85, covers the supply of Biomerieux's proprietary microbiology testing equipment, reagents, and consumables for the period of July 1, 2024 to June 30, 2025. The award is placed under Biomerieux's existing Multiple Award Schedule (MAS) contract, which allows federal...